Literature DB >> 22191245

[Potential endovascular prophylaxis for pulmonary thromboembolism in the combined treatment of cancer patients].

A V Bocharov, V G Cherenkov, A P Ukhanov, V I Chentsov.   

Abstract

Our study was concerned with the role of ultrasound examination of the lower extremity veins to detect deep venous thrombosis and to evaluate complex prophylaxis of thromboembolism of pulmonary arteries (TEPA). The procedure involved vena cava filter placement in patients with neoplasia and high risk of TEPA as compared with controls receiving conservative therapy alone. A positive correlation was established between surgery and/or polychemotherapy, on the one hand, and higher stage and high risk of TEPA, on the other. Patients with deep venous thrombosis and neoplasia were referred to groups of extremely high risk of that pathology. Angiological history, physical examination and ultrasound check-ups of the lower vein must be carried out in cancer patients. Vena cava filter placement proved to be an effective and safe measure of TEPA prophylaxis. It lowered the risk of lethal outcome in 24 during surgery and polychemotherapy. Lethality rate among controls was 43.5 +/- 0.51%.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22191245

Source DB:  PubMed          Journal:  Vopr Onkol        ISSN: 0507-3758


  3 in total

Review 1.  Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Authors:  Marcello Di Nisio; Ettore Porreca; Matteo Candeloro; Michele De Tursi; Ilaria Russi; Anne Ws Rutjes
Journal:  Cochrane Database Syst Rev       Date:  2016-12-01

2.  Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Authors:  Anne Ws Rutjes; Ettore Porreca; Matteo Candeloro; Emanuele Valeriani; Marcello Di Nisio
Journal:  Cochrane Database Syst Rev       Date:  2020-12-18

3.  Vena caval filters for the prevention of pulmonary embolism.

Authors:  Tim Young; Krishna Bajee Sriram
Journal:  Cochrane Database Syst Rev       Date:  2020-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.